The utility of assaying the N-terminal of brain natriuretic peptide precursor (NT pro-BNP) to predict the clinical outcome in patients with supraventricular tachyarrhythmias observed and treated in the emergency room;Utilità del dosaggio del precursore del peptide natriuretico cerebrale come predittore di cardioversione efficace nei pazienti con tachicardie e tachiaritmie sopraventricolari, osservati e trattati in Pronto Soccorso

Recenti Progressi in Medicina

Volumn 99, Issue 3, 2008, Pages 141-145

  Magioncalda, Antonio ^a,c   Sartini, Marina ^b   Costaguta, Chiara ^a   Castellaneta, Marco ^a   Schenone, Emanuela ^a   Tognoni, Elisabetta ^a   Pierluigi, Daniela ^a   Cremonesi, Paolo ^a  

^a GALLIERA HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE   (Italy)

Author keywords

Emergency room; Natriuretic peptide; NT proBNP terminal; SVTa observation unit; Synus rythm

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARDIOVERSION; ECHOCARDIOGRAPHY; EMERGENCY WARD; FINANCIAL MANAGEMENT; HEALTH CARE PLANNING; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 42249110727     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail 2001; 3: 283-91.
2. Santini M, De Ferrari GM, et al. Atrial fibrillation requiring urgent medical care. Date from the atrial fibrillation/flutter Italian Registry (FIRE). Ital Heart J 2004; 5: 205-13.
3. Go AS, et al. Dates from The ATRIA Study. JAMA 2001; 285: 2370-5.
4. Regione Liguria. Statistical Annual Report 2003.
5. McNamara RL, Tamariz LJ, Segal JB, Bass EB. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med 2003; 139: 1018-33.
6. Beck da Silva L, De Bold A, Fraser M, Williams K, Haddad H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 2004; 20: 1245-8.
7. The AFFIRM investigators (Wyse DG, Waldo AL, Di Marco JP, Domanski MJ, Rosenberg Y, Schron EB, et al.). A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-33.
8. Shelton RJ, et al. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT) ANP and (NT-pro) BNP. Europace 2007; 9: 147.
9. Peacock WF. Rapid optimization: strategies for optimal care of decompensated congestive heart failure patients in the Emergency Department. Rev Cardiovasc Med 2002; 3 (suppl 4): 41-8.
10. Aspromonte N, Canali C, Carbonieri E, et al. BNP-guided treatment of patients hospitalised with acute heart failure enables the timing of the patient's discharge to be optimised and can predict the medium-term risk. Acute Cardiac Care, Rome 2004, European Society of Cardiology. Abstract Book: 94.
11. Steinhoff JP, Sheahan RG. Tachycardia-induced cardiomyopathy: atrial fibrillation and congestive heart failure. American Med Science 2005; 329: 25-8.
12. Genest J, Cantin M. Atrial natriuretic factor. Circulation 1987; 75 (suppl I): I-118 I-24.
13. Richards AM, Crozier IG, Yandle TG, et al. Brain natriuretic factor: regional plasma concentrations and correlation with haemodynamic state in cardiac disease. Br Heart J 1993; 69: 414-7.
14. Troughton RW Richards AM. BNP for clinical monitoring of heart failure. Heart Fail Clin 2006; 2: 333-43.
15. Sochou M, Gustafsson F, Correll P, et al. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure. Am Heart J 2007;154: 123-9.
16. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993; 132: 1961-70.
17. Kazanegra R, Chen V, Garcia A, et al. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure:a pilot study. J Card Failure 2001; 7: 21-9.
18. Kellett J. The prediction of in-hospital mortality by amino terminal pro-brain natriuretic peptide (NT-proBNP) levels and other independent variables in acutely ill patients with suspected heart disease. Eur J Intern Med 2005; 16: 195-9.